Dr. David S. Hanson
Claim this profileMary Bird Perkins Cancer Center
Expert in Cancer
Expert in Lung Cancer
38 reported clinical trials
82 drugs studied
About David S. Hanson
Education:
- Obtained an MD from the University of Colorado School of Medicine, 1985.
- Graduated summa cum laude with an undergraduate degree in Biological Science from the University of Denver.
Experience:
- Possesses over 37 years of experience in Hematology & Oncology.
- Board-certified in Medical Oncology and Internal Medicine.
- Completed internship, residency, and fellowship in Hematology and Oncology at the University of Colorado Health Science Center.
- Serves as a Senior Consultant of Hematology and Oncology services at the Mayo Clinic in Jacksonville, Florida, since 1994.
- Currently practicing at Mary Bird Perkins Cancer Center in Baton Rouge, LA.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials David S. Hanson is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about David S. Hanson
Clinical Trial Related4 years of experience running clinical trials · Led 38 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments David S. Hanson has experience with
- Nivolumab
- Cisplatin
- Atezolizumab
- Paclitaxel
- Ipilimumab
- Carboplatin
Breakdown of trials David S. Hanson has run
Cancer
Lung Cancer
Breast Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David S. Hanson specialize in?
David S. Hanson focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is David S. Hanson currently recruiting for clinical trials?
Yes, David S. Hanson is currently recruiting for 10 clinical trials in Baton Rouge Louisiana. If you're interested in participating, you should apply.
Are there any treatments that David S. Hanson has studied deeply?
Yes, David S. Hanson has studied treatments such as Nivolumab, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with David S. Hanson?
Apply for one of the trials that David S. Hanson is conducting.
What is the office address of David S. Hanson?
The office of David S. Hanson is located at: Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana 70809 United States. This is the address for their practice at the Mary Bird Perkins Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.